Open AccessA mathematical model of oncolytic virotherapy with time delay
Author(s) -
Zizi Wang,
Zhi Ming Guo,
Hal L. Smith
Publication year - 2019
Publication title -
mathematical biosciences and engineering
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.451
H-Index - 45
eISSN - 1551-0018
pISSN - 1547-1063
DOI - 10.3934/mbe.2019089
Subject(s) - oncolytic virus , lytic cycle , virotherapy , herpes simplex virus , virus , virology , viral replication , ctl* , biology , measles virus , immune system , immunology , measles , vaccination , cd8
Oncolytic virotherapy is an emerging treatment modality which uses replication-competent viruses to destroy cancers without causing harm to normal tissues. By the development of molecular biotechnology, many effective viruses are adapted or engineered to make them cancer-specific, such as measles, adenovirus, herpes simplex virus and M1 virus. A successful design of virus needs a full understanding about how viral and host parameters influence the tumor load. In this paper, we propose a mathematical model on the oncolytic virotherapy incorporating viral lytic cycle and virus-specific CTL response. Thresholds for viral treatment and virus-specific CTL response are obtained. Different protocols are given depending on the thresholds. Our results also support that immune suppressive drug can enhance the oncolytic effect of virus as reported in recent literature.